Zacks: Analysts Anticipate CryoPort Inc (CYRX) Will Announce Quarterly Sales of $4.99 Million

Share on StockTwits

Equities analysts expect that CryoPort Inc (NASDAQ:CYRX) will post $4.99 million in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for CryoPort’s earnings. The highest sales estimate is $5.26 million and the lowest is $4.70 million. CryoPort posted sales of $3.00 million in the same quarter last year, which would indicate a positive year over year growth rate of 66.3%. The company is expected to issue its next quarterly earnings results after the market closes on Thursday, November 8th.

On average, analysts expect that CryoPort will report full-year sales of $19.20 million for the current financial year, with estimates ranging from $18.60 million to $19.88 million. For the next year, analysts expect that the business will post sales of $35.72 million, with estimates ranging from $32.65 million to $40.50 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for CryoPort.

CryoPort (NASDAQ:CYRX) last issued its earnings results on Thursday, August 9th. The consumer goods maker reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.02). The business had revenue of $4.63 million for the quarter, compared to the consensus estimate of $4.36 million. CryoPort had a negative net margin of 62.80% and a negative return on equity of 45.60%. The company’s revenue for the quarter was up 58.6% on a year-over-year basis.

Several analysts have commented on the stock. BidaskClub cut shares of CryoPort from a “buy” rating to a “hold” rating in a research report on Wednesday, August 15th. Cowen upped their target price on shares of CryoPort from $11.00 to $16.00 and gave the company an “outperform” rating in a research report on Monday, August 13th. Finally, B. Riley initiated coverage on shares of CryoPort in a research report on Wednesday, October 10th. They set a “buy” rating and a $22.00 target price for the company. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. CryoPort currently has a consensus rating of “Buy” and a consensus price target of $19.75.

Shares of CryoPort stock traded up $0.34 on Wednesday, hitting $10.45. 1,101 shares of the company’s stock traded hands, compared to its average volume of 232,724. The stock has a market capitalization of $299.01 million, a price-to-earnings ratio of -30.97 and a beta of 1.10. CryoPort has a one year low of $6.02 and a one year high of $16.88.

In other news, CEO Richard J. Berman sold 20,000 shares of the business’s stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $12.81, for a total value of $256,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard J. Berman sold 10,000 shares of the business’s stock in a transaction on Thursday, September 6th. The shares were sold at an average price of $14.00, for a total transaction of $140,000.00. The disclosure for this sale can be found here. 9.60% of the stock is owned by insiders.

Several hedge funds have recently made changes to their positions in the company. Strs Ohio acquired a new position in CryoPort in the 2nd quarter worth $115,000. Metropolitan Life Insurance Co. NY acquired a new position in CryoPort in the 2nd quarter worth $136,000. FNY Investment Advisers LLC acquired a new position in CryoPort in the 3rd quarter worth $147,000. Greenwood Capital Associates LLC acquired a new position in CryoPort in the 2nd quarter worth $163,000. Finally, MetLife Investment Advisors LLC acquired a new position in CryoPort in the 2nd quarter worth $192,000. 48.42% of the stock is owned by institutional investors.

CryoPort Company Profile

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Recommended Story: What is a Tariff?

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply